BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19299451)

  • 81. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
    Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
    Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells.
    Zhang W; Niu M; Yan K; Zhai X; Zhou Q; Zhang L; Zhou Y
    Int J Biochem Cell Biol; 2013 Mar; 45(3):736-44. PubMed ID: 23295202
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
    Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling.
    Duan NN; Liu XJ; Wu J
    Life Sci; 2017 May; 176():42-53. PubMed ID: 28322865
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
    He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
    Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
    Fujinaga Y; Kawaratani H; Kaya D; Tsuji Y; Ozutsumi T; Furukawa M; Kitagawa K; Sato S; Nishimura N; Sawada Y; Takaya H; Kaji K; Shimozato N; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759852
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
    Fu Y; Chen A
    Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Curcumin interrupts leptin-regulated microRNA-122 in hepatic stellate cells in vitro and in vivo.
    Limin H; Feifan X
    Pak J Pharm Sci; 2023 Mar; 36(2):417-423. PubMed ID: 37530148
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Curcumin adds spice to the debate: lipid metabolism in liver disease.
    Graham A
    Br J Pharmacol; 2009 Aug; 157(8):1352-3. PubMed ID: 19681867
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An unusual signal transducer GIV/Girdin engages in the roles of adipocyte-derived hormone leptin in liver fibrosis.
    Jia X; Xu F; Lu S; Jie H; Guan W; Zhou Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166797. PubMed ID: 37478565
    [TBL] [Abstract][Full Text] [Related]  

  • 91. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases.
    Shehzad A; Ha T; Subhan F; Lee YS
    Eur J Nutr; 2011 Apr; 50(3):151-61. PubMed ID: 21442412
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation.
    Li T; Shi Z; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G948-57. PubMed ID: 22301113
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Epigenetic cell fate regulation of hepatic stellate cells.
    Tsukamoto H; Zhu NL; Asahina K; Mann DA; Mann J
    Hepatol Res; 2011 Jul; 41(7):675-82. PubMed ID: 21504520
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.
    Aggarwal BB
    Annu Rev Nutr; 2010 Aug; 30():173-99. PubMed ID: 20420526
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line.
    Dalimi-Asl S; Babaahmadi-Rezaei H; Mohammadzadeh G
    Iran J Med Sci; 2020 Nov; 45(6):477-484. PubMed ID: 33281265
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Are we approaching a holistic view of leptin's role in arthritis?
    Gualillo O
    Osteoarthritis Cartilage; 2023 Jan; 31(1):21-22. PubMed ID: 36243310
    [No Abstract]   [Full Text] [Related]  

  • 97. Corrigendum to "Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH)" [Life Sci. 285 (2021) 119983].
    El-Hameed NMA; El-Aleem SAA; Khattab MA; Ali AH; Mohammed HH
    Life Sci; 2022 Mar; 292():120348. PubMed ID: 35065811
    [No Abstract]   [Full Text] [Related]  

  • 98. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder.
    Liu S; Li E; Sun Z; Fu D; Duan G; Jiang M; Yu Y; Mei L; Yang P; Tang Y; Zheng P
    Sci Rep; 2019 Jan; 9(1):287. PubMed ID: 30670726
    [TBL] [Abstract][Full Text] [Related]  

  • 99. NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    Tang Y; Blomenkamp KS; Fickert P; Trauner M; Teckman JH
    PLoS One; 2018; 13(8):e0200897. PubMed ID: 30067827
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.